KKR Sinks Its Teeth Into Henry Schein With Additional Investment And Board Seats: Details
Henry Schein, Inc. (NASDAQ:HSIC) shares are trading higher on Wednesday. The medical and dental supplies distributor disclosed a strategic investment of an additional $250 million from funds affiliated with KKR & Co.
Private equity firm KKR has taken a large stake in Henry Schein and plans to work with the distributor of medical products to ...
Barrington analyst Michael Petusky raised the firm’s price target on Henry Schein (HSIC) to $90 from $82 and keeps an Outperform rating on the ...
Providing a diverse range of perspectives from bullish to bearish, 5 analysts have published ratings on Henry Schein HSIC in the last three months. The table below offers a condensed view of their ...
Shares of Henry Schein Inc. advanced 4.95% to $79.87 Wednesday, on what proved to be an all-around poor trading session for ...
Henry Schein (HSIC – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Allen Lutz from ...
Activist investor Ananym Capital Management plans to nominate as many as half a dozen directors to the board at Henry Schein ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback